, Tracking Stock Market Picks
Enter Symbol:
Affymetrix, Inc. (AFFX) [hlAlert]

down 18.21 %

Affymetrix, Inc. (AFFX) rated Underweight by Morgan Stanley

Posted on: Monday,  Jan 6, 2014  9:25 AM ET by Morgan Stanley

Morgan Stanley rated Underweight Affymetrix, Inc. (NASDAQ: AFFX) on 01/06/2014, when the stock price was $7.90. Since
then, Affymetrix, Inc. has gained 22.28% as of 01/25/2016's recent price of $9.66.
If you would have followed this Morgan Stanley's recommendation on AFFX, you would have lost 18.21% of your investment in 749 days.

Affymetrix scientists invented the world's first high-density microarray and began selling the first commercial microarray. Since then, Affymetrix GeneChip technology has become the industry standard in molecular biology research. Affymetrix technology is used by the world's top pharmaceutical, diagnostic and biotechnology companies as well as leading academic, government and not-for-profit research institutes. Affymetrix' patented photolithographic manufacturing process provides the most information capacity available today on an array, enabling researchers to use a whole-genome approach to analyzing the relationship between genetics and health.

Morgan Stanley Investment Research is one of the financial industry's dominant thought leaders in equity and fixed-income investing. Our analysts, economists, and strategists have earned this reputation through timely, in-depth analysis of companies, industries, markets, and the world’s economies. Our teams collaborate to assist Morgan Stanley clients with investment decisions, using cash and derivative instruments across major asset classes and geographies.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/6/2014 9:25 AM Sell
as of 10/17/2014
1 Week down  -3.94 %
1 Month up  11.72 %
3 Months up  8.55 %
1 YTD up  6.58 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy